fbpx

New treatment for obesity caused by rare genetic disorders, CHMP, 21/05/2021

Share on facebook
Share on twitter
Share on pinterest

EMA has recommended granting a marketing authorisation in the European Union (EU) for Imcivree (setmelanotide) to support weight loss and -management in…

Share this post with your friends

Share on facebook
Share on google
Share on twitter
Share on linkedin

Leave a Reply

Do You Want To Boost Your Business?

Send Me Your Press Release and I'll Blast it Out To The World -- It's Free

%d bloggers like this: